Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to find out whether changing the hospital policy to allow
switch from glycopeptide antibiotics (given by intravenous drip), to an equally effective
oral antibiotic (linezolid) will enable patients who are otherwise well enough to be
discharged from hospital sooner.
The secondary objectives are
1. To identify those patients who could potentially be discharged on an oral agent from
those being treated with a glycopeptide, thus helping target this approach most
effectively
2. To evaluate the cost involved and compare this with the costs that would have taken
place if use of an oral agent and discharge had not occurred.